Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
GreenLight Metals Announces U.S. Trading on the OTCQB Venture Market Under Symbol "GRLMF"
-
C3 Metals Restarts Full Exploration Activities in Jamaica Following Community Assistance Programs After Hurricane Melissa
-
GoGuardian Launches Hall Pass for Safer Hallways, More Classroom Learning
-
American Pacific Provides Update on Plan of Arrangement with ICG Silver & Gold Ltd. and Completes Share Payments to Three Former Employees
-
Helios HVACR deploys A.I. nationwide in partnership with Bluon
-
IN TWO WEEKS: Little Rock Students to Shine in School Choice Showcase
-
Gaming and Leisure Properties, Inc. Schedules Fourth Quarter 2025 Earnings Release and Conference Call
-
NexGold Provides Summary of 2025 Activities and Key Priorities for 2026
-
Canada’s Biggest Popcorn Celebration: Cineplex Expands National Popcorn Day to Four Days
-
P10 Announces Upcoming Name Change
-
KEY Investment Partners Acquires BellRock Brands’ Portfolio, Home of Mary’s Medicinals, Dixie and Other Top Names
-
RAD Increases Ownership in Radiopharm Ventures to 87.5%
-
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
-
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
-
Lyra Therapeutics Provides Corporate Update
-
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
-
Independence Power Holdings, Inc. Completes Business Combination/Reverse Merger with TriUnity Business Services; Addresses Permian Basin Power Shortfall with Software-Driven Microgrids
-
Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey, Mobilizes Stone Island VTEM Survey
-
Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
-
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2025
-
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
-
Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD
-
Golden Arrow Confirms Near-Surface Gold Zone with Trench Results including 76.7m @ 1.01 g/t Au at Noemi Gold Target, San Pietro Project, Chile
-
GTCR Completes Sale of Worldpay to Global Payments
-
Accredant Capital Advises Segue Sustainable Infrastructure on Sale of Community Solar Portfolio to Radial Power
-
A2Z Cust2Mate Expands into Toy Retail with Large-Scale Smart Cart Deployments
-
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
-
Avista-Backed WellSpring Consumer Healthcare Acquires Established OTC Skincare Brands, DerMend® and Recticare®
-
NEXT with Michael Sonnenfeldt Returns for Season 2, Featuring Visionary Entrepreneurs Shaping What Comes Next
-
Zumiez Inc. Reports Holiday 2025 Sales Results
-
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
-
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2025
-
Brookdale Reports December 2025 Occupancy
-
ARTBIO Announces Dosing of Two Cohorts with AB001 in ARTISAN, a Phase 1 Alpha Radioligand Therapy Clinical Trial for Metastatic Castration Resistant Prostate Cancer
-
Emerita Resources Provides Corporate Update
-
Waystar Introduces Agentic AI to Advance Toward the Autonomous Revenue Cycle
-
TGI Fridays Unveils Bold Vision to Become Global Casual Dining Leader
-
Skye Provides 2026 Corporate Outlook
-
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
-
EDETEK to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
-
New 2026 ezPaycheck Supports the One Big Beautiful Bill!
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
-
Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
-
Highwoods Announces Investment Activity
-
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
-
Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production
-
MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026
-
Surya Oil & Gas Corp. Appoints CFO as Company Enters Execution Phase Across West Virginia and Texas
